Literature DB >> 19369579

Use-dependent block of voltage-gated Cav2.1 Ca2+ channels by petasins and eudesmol isomers.

Silja Horak1, Alexandra Koschak, Hermann Stuppner, Jörg Striessnig.   

Abstract

Migraine is a frequent and often disabling disease. Treatment is unsatisfactory in many patients. A disturbed dynamic balance between excitatory and inhibitory signal processing with enhanced cortical activity probably underlies common forms of migraine. Presynaptic voltage-gated Ca(2+) channels are critical determinants of neurotransmitter release and also contribute to trigeminovascular signal transduction. Because clinical evidence exists for migraine-prophylactic actions of Petasites hybridus extracts, we investigated whether petasins comprising the main constituents of the extract inhibit currents through presynaptic Ca(v)2.1 channels expressed in Xenopus laevis oocytes. P. hybridus extract (0.02 mg/ml), petasin, neopetasin, isopetasin, S-petasin, and iso-S-petasin (50 microM) were weak tonic blockers of Ca(v)2.1-mediated barium currents (I(Ba)) during infrequent depolarizations (0.1 Hz), but their inhibitory potency increased at higher stimulation rates (1 Hz), indicating preferential block of open and/or inactivated channels. Sulfur-containing compounds (S-petasin, Iso-S-petasin) were the most potent significantly promoting the accumulation of Ca(v)2.1 channel in inactivated states during pulse trains (I(Ba) decrease during 1-Hz pulse trains: control, 45%, S-petasin, 79%; iso-S-petasin, 80%). For the Eucalyptus williamsiania sesquiterpenes alpha- and gamma-eudesmol, a comparable use-dependent inhibition was found in addition to a tonic block component. Alpha-eudesmol and petasins accelerated the voltage-dependent inactivation of Ca(v)2.1 channels during depolarizations. We demonstrate that S-petasin, iso-S-petasin, and eudesmol are Ca(v)2.1 channel inhibitors preferentially acting as use-dependent channel blockers and with the sulfur-containing substituent in position 3 of the petasins serving as important functional feature. The Ca(v)2.1-inhibitory properties of these petasins may contribute to migraine-prophylactic properties described for P. hybridus extracts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369579     DOI: 10.1124/jpet.109.151183

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

Review 1.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review.

Authors:  Jürgen Borlak; Hans-Christoph Diener; Johanna Kleeberg-Hartmann; Karl Messlinger; Stephen Silberstein
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

3.  Therapeutic effects of s-petasin on disease models of asthma and peritonitis.

Authors:  Kyoung-Pil Lee; Saeromi Kang; Min-Soo Noh; Soo-Jin Park; Jung-Min Kim; Hae Young Chung; Nam Kyung Je; Young-Geun Lee; Young-Whan Choi; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2015-01-01       Impact factor: 4.634

4.  Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels.

Authors:  Johanna Kleeberg-Hartmann; Birgit Vogler; Karl Messlinger
Journal:  J Headache Pain       Date:  2021-04-13       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.